FDA applicant

Sanofi Genzyme Corp.

Cambridge1 decision1997–19971 recall

FDA records 1 decision for Sanofi Genzyme Corp. (Cambridge) in 1997: 1 original PMA approval. All are in product code MOZ (Acid, Hyaluronic, Intraarticular). 1 recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, orthopedic panel, where it files most

How often FDA has decided Sanofi Genzyme Corp.’s devices, and how often a recall has named them.

FDA decisions per year

No FDA decision for Sanofi Genzyme Corp. since 2007.

Recalls per year

1in 2017

2007high 1 (2017) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Sanofi Genzyme Corp. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Sanofi Genzyme Corp.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Sanofi”

FDA records each applicant name separately; these may or may not be the same firm.

Sanofi, Inc. 2 Sanofi Aventis U.S., LLC 1

Sanofi Genzyme Corp.

Which product codes does it file in?

What has FDA decided for it lately?

What has been recalled?

Other applicant names beginning “Sanofi”